Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioniCare Medical Technologies is a medical device company that developed the first non-invasive, non-drug electrical stimulation treatment for osteoarthritis of the knee. The company's core technology, Pulsed Electrical Stimulation (PES), is designed to mimic the body's natural signals to stimulate joint tissue and improve the health of the joint environment. Its flagship product, the BioniCare System (formerly BIO-1000), received FDA clearance for the treatment of osteoarthritic knee pain and symptoms. In 2006, the company was acquired by VQ OrthoCare, which integrated the technology into its line of orthopedic solutions, often combining it with specialized bracing. The treatment is clinically proven to provide long-term relief and improve function for patients who have failed conservative treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioniCare Medical Technologies.